Trademark: 79274531
Status Date
Tuesday, January 19, 2021
Registration Number
6248000
Registration Date
Tuesday, January 19, 2021
Filing Date
Friday, November 8, 2019
Published for Opposition
Tuesday, November 3, 2020
5 Pharmaceutical preparations and substances for the treatment and/or diagnosis of cancer and infectious diseases; biotechnologically-formed enzyme preparations for medical purposes; medicinal preparations for the treatment of cancer and infectious diseases; monoclonal antibodies for therapeutic purposes; products containing antibodies for use in medicine, namely, diagnostic kits consisting primarily of monoclonal antibodies used in the capture of exosomes and other extra cellular vesicles for use in disease testing; proteins for binding antibodies for medical use; proteins for detecting antibodies for medical use; reagents for medical use, namely, for use in the development of monoclonal antibodies; diagnostic biomarker reagents for medical purposes; tagged antibodies for medical use; vaccines; vaccines against cancer, viral, and bacterial infection; vaccines for human use; diagnostic preparations and reagents for medical purposes; vaccine adjuvants; diagnostic preparations, reagents, and substances for medical purposes; diagnostic products and testing materials for medical purposes, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in capturing and purifying exosomes and other extra cellular vesicles for use in disease testing; reagents for use in diagnostic tests for medical purposes; medical diagnostic reagents for capturing and purifying exosomes and other extra cellular vesicles that can be utilised in therapeutics or diagnostics; cells for growing recombinant human protein for medical purposes; recombinant DNA technology proteins for medical use; biological reagents for use in molecular biology, namely, reagents for medical use for capturing and purifying exosomes and other extra cellular vesicles that contain nucleic acid; antibodies that are specifically able to bind and capture exosomes and other extra cellular vesicles for medical purposes; antibody fragments that are specifically able to bind and capture exosomes and other extra cellular vesicles for medical purposes; antibody conjugates that are specifically able to bind and capture exosomes and other extra cellular vesicles for medical purposes; pharmaceutical preparations for the treatment, reconstruction and repair of antibodies; immunological antibodies for medical use; monoclonal antibodies for medical diagnostic use; monoclonal antibodies for medical use
May 16, 2021
Final Decision Transaction Processed By Ib
Apr 24, 2021
Final Disposition Notice Sent To Ib
Apr 23, 2021
Final Disposition Processed
Apr 19, 2021
Final Disposition Notice Created, To Be Sent To Ib
Jan 29, 2021
Change Of Name/Address Rec'd From Ib
Jan 19, 2021
Registered-Principal Register
Nov 3, 2020
Official Gazette Publication Confirmation E-Mailed
Nov 3, 2020
Published For Opposition
Nov 2, 2020
Notification Processed By Ib
Oct 14, 2020
Notification Of Possible Opposition Sent To Ib
Oct 14, 2020
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Oct 14, 2020
Notification Of Notice Of Publication E-Mailed
Sep 24, 2020
Approved For Pub - Principal Register
Sep 10, 2020
Teas/Email Correspondence Entered
Sep 9, 2020
Correspondence Received In Law Office
Sep 9, 2020
Teas Response To Office Action Received
Mar 27, 2020
Refusal Processed By Ib
Mar 9, 2020
Non-Final Action Mailed - Refusal Sent To Ib
Mar 9, 2020
Refusal Processed By Mpu
Feb 19, 2020
Non-Final Action (Ib Refusal) Prepared For Review
Feb 18, 2020
Non-Final Action Written
Feb 12, 2020
Assigned To Examiner
Dec 27, 2019
Application Filing Receipt Mailed
Dec 23, 2019
New Application Office Supplied Data Entered In Tram
Dec 19, 2019
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
